RETRACTED: Uncovering the pathogenesis and identifying novel targets of pancreatic cancer using bioinformatics approach (Retracted article. See vol. 42, pg. 1463, 2015)

被引:2
作者
Zhao, Li-Li [1 ]
Zhang, Tong [2 ]
Zhuang, Li-Wei [1 ]
Yan, Bing-Zhu [3 ]
Wang, Rui-Feng [1 ]
Liu, Bing-Rong [4 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 4, Dept Gastroenterol, Harbin 150001, Heilongjiang, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 4, Dept Cardiol, Harbin 150001, Heilongjiang, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 2, Dept Infect Dis, Harbin 150001, Heilongjiang, Peoples R China
[4] Harbin Med Univ, Affiliated Hosp 2, Dept Gastroenterol, Harbin 150001, Heilongjiang, Peoples R China
关键词
Pancreatic cancer; Differentially expressed gene; Functional analysis; Protein-protein interaction network; Text mining; SIGNALING PATHWAY; CELL-ADHESION; EXPRESSION; GENE; DYNAMICS; BIOLOGY; GROWTH;
D O I
10.1007/s11033-014-3340-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pancreatic cancer is a uniformly lethal disease that can be difficult to diagnose at its early stage. Thus, our present study aimed to explore the underlying mechanism and identify new targets for this disease. The data GSE16515, including 36 tumor and 16 normal samples were available from Gene Expression Omnibus. Differentially expressed genes (DEGs) were screened out using Robust Multichip Averaging and LIMMA package. Moreover, gene ontology and pathway enrichment analyses were performed to DEGs. Followed with protein-protein interaction (PPI) network construction by STRING and Cytoscape, module analysis was conducted using ClusterONE. Finally, based on PubMed, text mining about these DEGs was carried out. Total 274 up-regulated and 93 down-regulated genes were identified as the common DEGs and these genes were discovered significantly enriched in cell adhesion and extracellular region terms, as well as ECM-receptor interaction pathway. In addition, five modules were screened out from the up-regulated PPI network with none in down-regulated network. Finally, the up-regulated genes, including MIA, MET and CEACAMS, and down-regulated genes, such as FGF, INS and LAPP, had the most references in text mining analysis. Our findings demonstrate that the up- and down-regulated genes play important roles in pancreatic cancer development and might be new targets for the therapy.
引用
收藏
页码:4697 / 4704
页数:8
相关论文
共 35 条
[1]  
Andrianifahanana M, 2001, CLIN CANCER RES, V7, P4033
[2]  
Aoki-Kinoshita Kiyoko F., 2007, V396, P71
[3]   The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-κB and c-Myc in pancreatic cancer cells [J].
Asano, T ;
Yao, YX ;
Zhu, JJ ;
Li, DH ;
Abbruzzese, JL ;
Reddy, SAG .
ONCOGENE, 2004, 23 (53) :8571-8580
[4]   Gene Ontology: tool for the unification of biology [J].
Ashburner, M ;
Ball, CA ;
Blake, JA ;
Botstein, D ;
Butler, H ;
Cherry, JM ;
Davis, AP ;
Dolinski, K ;
Dwight, SS ;
Eppig, JT ;
Harris, MA ;
Hill, DP ;
Issel-Tarver, L ;
Kasarskis, A ;
Lewis, S ;
Matese, JC ;
Richardson, JE ;
Ringwald, M ;
Rubin, GM ;
Sherlock, G .
NATURE GENETICS, 2000, 25 (01) :25-29
[5]   Pancreatic cancer biology and genetics [J].
Bardeesy, N ;
DePinho, RA .
NATURE REVIEWS CANCER, 2002, 2 (12) :897-909
[6]   Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death:: role of the β4 integrin and the PI3k pathway [J].
Baril, P. ;
Gangeswaran, R. ;
Mahon, P. C. ;
Caulee, K. ;
Kocher, H. M. ;
Harada, T. ;
Zhu, M. ;
Kalthoff, H. ;
Crnogorac-Jurcevic, T. ;
Lemoine, N. R. .
ONCOGENE, 2007, 26 (14) :2082-2094
[7]   The FGF family: biology, pathophysiology and therapy [J].
Beenken, Andrew ;
Mohammadi, Moosa .
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (03) :235-253
[8]   Will Detection of MicroRNA Biomarkers in Blood Improve the Diagnosis and Survival of Patients With Pancreatic Cancer? [J].
Buchsbaum, Donald J. ;
Croce, Carlo M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (04) :363-365
[9]   The patterns and dynamics of genomic instability in metastatic pancreatic cancer [J].
Campbell, Peter J. ;
Yachida, Shinichi ;
Mudie, Laura J. ;
Stephens, Philip J. ;
Pleasance, Erin D. ;
Stebbings, Lucy A. ;
Morsberger, Laura A. ;
Latimer, Calli ;
McLaren, Stuart ;
Lin, Meng-Lay ;
McBride, David J. ;
Varela, Ignacio ;
Nik-Zainal, Serena A. ;
Leroy, Catherine ;
Jia, Mingming ;
Menzies, Andrew ;
Butler, Adam P. ;
Teague, Jon W. ;
Griffin, Constance A. ;
Burton, John ;
Swerdlow, Harold ;
Quail, Michael A. ;
Stratton, Michael R. ;
Iacobuzio-Donahue, Christine ;
Futreal, P. Andrew .
NATURE, 2010, 467 (7319) :1109-1113
[10]   Discovery of a Novel Class of Exquisitely Selective Mesenchymal-Epithelial Transition Factor (c-MET) Protein Kinase Inhibitors and Identification of the Clinical Candidate 2-(4-(1-(Quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (PF-04217903) for the Treatment of Cancer [J].
Cui, J. Jean ;
McTigue, Michele ;
Nambu, Mitchell ;
Tran-Dube, Michelle ;
Pairish, Mason ;
Shen, Hong ;
Jia, Lei ;
Cheng, Hengmiao ;
Hoffman, Jacqui ;
Le, Phuong ;
Jalaie, Mehran ;
Goetz, Gilles H. ;
Ryan, Kevin ;
Grodsky, Neil ;
Deng, Ya-Li ;
Parker, Max ;
Timofeevski, Sergei ;
Murray, Brion W. ;
Yamazaki, Shinji ;
Aguirre, Shirley ;
Li, Qiuhua ;
Zou, Helen ;
Christensen, James .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (18) :8091-8109